Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 38825 for Org 36286 (Corifollitropin Alfa)
Brief Summary: The objective of this trial is to evaluate whether corifollitropin alfa (Org 36286) treatment for the induction of multifollicular growth in women undergoing controlled ovarian stimulation (COS) prior to in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) is safe for pregnant participants and their offspring. In addition, a primary efficacy variable, live birth rate, was evaluated.


Options:
A: Arm Label: Women/Expectant Mothers - Corifollitropin Alfa 150 µg; Type: N/A; Interventions: Biological: Corifollitropin alfa, Biological: GnRH antagonist, Biological: (rec)hCG, Biological: FSH, Drug: Progesterone | Intervention Type: BIOLOGICAL; Name: Corifollitropin alfa; Assigned to Arm(s): Women/Expectant Mothers - Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: GnRH antagonist; Assigned to Arm(s): Women/Expectant Mothers - Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: (rec)hCG; Assigned to Arm(s): Women/Expectant Mothers - Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: FSH; Assigned to Arm(s): Women/Expectant Mothers - Corifollitropin Alfa 150 µg | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Women/Expectant Mothers - Corifollitropin Alfa 150 µg
B: Arm Label: Corifollitropin alfa 150 µg; Type: EXPERIMENTAL; Interventions: Drug: Corifollitropin alfa, Biological: FSH, Biological: GnRH antagonist, Biological: (rec)hCG, Drug: Progesterone | Intervention Type: DRUG; Name: Corifollitropin alfa; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: FSH; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: GnRH antagonist; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: (rec)hCG; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Corifollitropin alfa 150 µg
C: Arm Label: Mothers Corifollitropin Alfa 150 µg; Type: N/A; Interventions: Drug: Corifollitropin Alfa 150 μg, Drug: Placebo for RecFSH/Follitropin beta, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Arm Label: Mothers recFSH 200 IU; Type: N/A; Interventions: Biological: 200 IU RecFSH/Follitropin beta (Days 1 to 7), Drug: Placebo for Corifollitropin Alfa, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Intervention Type: DRUG; Name: Corifollitropin Alfa 150 μg; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 1 to 7); Assigned to Arm(s): Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Placebo for Corifollitropin Alfa; Assigned to Arm(s): Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Placebo for RecFSH/Follitropin beta; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 8 to hCG); Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Ganirelix; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: BIOLOGICAL; Name: hCG; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: BIOLOGICAL; Name: Progesterone; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU
D: Arm Label: 150 µg Corifollitropin Alfa; Type: EXPERIMENTAL; Interventions: Drug: Corifollitropin alfa, Drug: Placebo RecFSH / follitropin beta, Biological: RecFSH / Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Arm Label: 200 IU recFSH; Type: ACTIVE_COMPARATOR; Interventions: Biological: RecFSH / Follitropin beta (Days 1 to 7), Drug: Placebo Corifollitropin alfa, Biological: RecFSH / Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Intervention Type: DRUG; Name: Corifollitropin alfa; Assigned to Arm(s): 150 µg Corifollitropin Alfa | Intervention Type: BIOLOGICAL; Name: RecFSH / Follitropin beta (Days 1 to 7); Assigned to Arm(s): 200 IU recFSH | Intervention Type: DRUG; Name: Placebo Corifollitropin alfa; Assigned to Arm(s): 200 IU recFSH | Intervention Type: DRUG; Name: Placebo RecFSH / follitropin beta; Assigned to Arm(s): 150 µg Corifollitropin Alfa | Intervention Type: BIOLOGICAL; Name: RecFSH / Follitropin beta (Days 8 to hCG); Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH | Intervention Type: DRUG; Name: Ganirelix; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH | Intervention Type: BIOLOGICAL; Name: hCG; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH | Intervention Type: BIOLOGICAL; Name: Progesterone; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH

Answer: A